Management Report
Management Report

4.6 Asset and Capital Structure of the ­Bayer Group

Bayer Group Summary Statements of Financial Position[Table 3.22]
 Dec. 31, 2009Dec. 31, 2010Change
 € million€ million%
Noncurrent assets34,04933,188-2.5
Current assets16,99318,318+7.8
Total assets51,04251,506+0.9
    
Equity18,95118,896-0.3
Noncurrent liabilities23,11821,775-5.8
Current liabilities8,97310,835+20.8
Liabilities 32,09132,610+1.6
Total equity and liabilities51,04251,506+0.9
Total assets increased in 2010 by 0.9% to €51.5 billion. Noncurrent assets declined by €0.9 billion to €33.2 billion, mainly due to amortization and impairments of intangible assets. Noncurrent assets included goodwill of €9.0 billion (2009: €8.7 billion), the increase being mainly due to shifts in exchange rates. Current assets rose by €1.3 billion compared with the previous year, to €18.3 billion.
Equity was almost level with the prior year at €18.9 billion, bolstered mainly by the €1.3 billion net income and €0.6 billion in positive currency effects. The €1.2 billion dividend payment made in 2010 and the €0.7 billion increase in pension obligations – recognized outside profit or loss – had the opposite effect. Our equity ratio (equity coverage of total assets) was 36.7% as of December 31, 2010 (2009: 37.1%).
Liabilities increased by €0.5 billion compared with December 31, 2009, to €32.6 billion, largely because of the increase in pension obligations and the allocations to provisions for litigations. Current and noncurrent financial liabilities declined by €1.1 billion to €11.8 billion.
Net Pension Liability[Table 3.23]
 Dec. 31, 2009Dec. 31, 2010
 € million€ million
Provisions for pensions and other post-employment benefits6,5177,305
Benefit plan assets in excess of obligation(100) (76)
Net pension liability6,4177,229
The net pension liability increased from €6.4 billion to €7.2 billion in 2010, due especially to lower long-term capital market interest rates. Provisions for pensions and other post-employment benefits rose from €6.5 billion to €7.3 billion. Benefit plan assets in excess of obligations, reflected in the statement of financial position as “Other receivables,” came to €0.1 billion (2009: €0.1 billion).
Ratios[Table 3.24]
  20092010
Cost of sales ratio (%)
Cost of goods sold48.648.7
Sales
R&D expense ratio (%)
Research and development expenses8.8
8.7
Sales
Return on sales (%)
Income after taxes4.43.7
Sales
EBIT margin (%)
EBIT 9.67.8
Sales
EBITDA margin before
special items (%)
EBITDA before special items 20.820.2
Sales

Asset intensity (%)
Property, plant and equipment
+ intangible assets

60.6

58.2
Total assets
D & A/capex ratio (%)
Depreciation and amortization* 159.4156.8
Capital expenditures *
Liability structure (%)
Current liabilities28.033.2
Liabilities

Gearing

Net debt + pension provisions
0.9
 

0.8
 
Equity
Free operating cash flow (€ million)
Net operating cash flow
less cash outflows for property, plant and
equipment and intangible assets
3,8004,259
Inventory turnover
Cost of goods sold 2.52.8
Inventories
Receivables turnoverSales 5.1
5.3
Trade accounts receivable
Payables turnoverCost of goods sold5.5
4.9
Trade accounts payable
Equity ratio (%)
Equity 37.136.7
Total assets
Return on equity (%)
Income after taxes7.76.9
Average equity

Return on assets (%)

Income before taxes and interest expense
6.1
 

5.1
 
Average total assets for the year
* property, plant and equipment + intangible assets
Last updated: February 28, 2011

http://www.annualreport2010.bayer.com/en/asset-and-capital-structure.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Services

Full Year 2010 Results

Info

Special Interest